Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration atropine for prevention of myopia onset in children
ChiCTR2500101180Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Apr 2025
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Change in spherical equivalent at 12 months. Started Apr 2025; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2500101180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101180.